HRP20050287A2 - Indole-3-carboxamides as glucokinase (gk) activators - Google Patents
Indole-3-carboxamides as glucokinase (gk) activatorsInfo
- Publication number
- HRP20050287A2 HRP20050287A2 HR20050287A HRP20050287A HRP20050287A2 HR P20050287 A2 HRP20050287 A2 HR P20050287A2 HR 20050287 A HR20050287 A HR 20050287A HR P20050287 A HRP20050287 A HR P20050287A HR P20050287 A2 HRP20050287 A2 HR P20050287A2
- Authority
- HR
- Croatia
- Prior art keywords
- glucokinase
- activators
- carboxamides
- indole
- diabetes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41573702P | 2002-10-03 | 2002-10-03 | |
| PCT/EP2003/010776 WO2004031179A1 (en) | 2002-10-03 | 2003-09-26 | Indole-3-carboxamides as glucokinase (gk) activators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20050287A2 true HRP20050287A2 (en) | 2006-12-31 |
Family
ID=32069904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20050287A HRP20050287A2 (en) | 2002-10-03 | 2005-03-24 | Indole-3-carboxamides as glucokinase (gk) activators |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6881844B2 (pt) |
| EP (1) | EP1549638B1 (pt) |
| JP (1) | JP4390704B2 (pt) |
| KR (1) | KR100646486B1 (pt) |
| CN (1) | CN100348596C (pt) |
| AR (1) | AR041467A1 (pt) |
| AT (1) | ATE374768T1 (pt) |
| AU (1) | AU2003270285B2 (pt) |
| BR (1) | BR0315047A (pt) |
| CA (1) | CA2499329C (pt) |
| DE (1) | DE60316709T2 (pt) |
| DK (1) | DK1549638T3 (pt) |
| ES (1) | ES2293005T3 (pt) |
| HK (1) | HK1083098A1 (pt) |
| HR (1) | HRP20050287A2 (pt) |
| MX (1) | MXPA05003391A (pt) |
| MY (1) | MY136764A (pt) |
| NO (1) | NO20051103L (pt) |
| NZ (1) | NZ538466A (pt) |
| PA (1) | PA8584001A1 (pt) |
| PE (1) | PE20050090A1 (pt) |
| PL (1) | PL375149A1 (pt) |
| PT (1) | PT1549638E (pt) |
| RU (1) | RU2309956C2 (pt) |
| SI (1) | SI1549638T1 (pt) |
| TW (1) | TW200413364A (pt) |
| UY (1) | UY28005A1 (pt) |
| WO (1) | WO2004031179A1 (pt) |
| ZA (1) | ZA200502619B (pt) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| CN1703408A (zh) * | 2002-10-03 | 2005-11-30 | 诺瓦提斯公司 | 作为葡糖激酶激活剂、可用于治疗ⅱ型糖尿病的取代的(噻唑－2－基)酰胺或磺酰胺 |
| GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| GB0226930D0 (en) * | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| EP1532980A1 (en) * | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| JP4700684B2 (ja) | 2004-04-02 | 2011-06-15 | ノバルティス アーゲー | ２型糖尿病の処置に有用なグルコキナーゼアクティベーターとしてのスルホンアミド−チアゾロピリジン誘導体 |
| EP1737870A1 (en) | 2004-04-02 | 2007-01-03 | Novartis AG | Thiazolopyridine derivates, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions |
| US8957070B2 (en) | 2005-04-20 | 2015-02-17 | Takeda Pharmaceutical Company Limited | Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity |
| US7622492B2 (en) | 2005-08-31 | 2009-11-24 | Hoffmann-La Roche Inc. | Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase |
| JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| CA2624102A1 (en) | 2005-09-29 | 2007-04-12 | Sanofi-Aventis | Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
| GT200600428A (es) * | 2005-09-30 | 2007-05-21 | Compuestos organicos | |
| GT200600429A (es) * | 2005-09-30 | 2007-04-30 | Compuestos organicos | |
| JP4990783B2 (ja) * | 2005-09-30 | 2012-08-01 | Ｍｓｄ株式会社 | ２−ヘテロアリール置換インドール誘導体 |
| JP2009013065A (ja) * | 2005-10-14 | 2009-01-22 | Astellas Pharma Inc | 縮合へテロ環化合物 |
| WO2007061923A2 (en) * | 2005-11-18 | 2007-05-31 | Takeda San Diego, Inc. | Glucokinase activators |
| US7351706B2 (en) * | 2006-01-05 | 2008-04-01 | Hoffmann-La Roche Inc. | Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| US8034822B2 (en) | 2006-03-08 | 2011-10-11 | Takeda San Diego, Inc. | Glucokinase activators |
| EP1849785A1 (en) * | 2006-04-28 | 2007-10-31 | Neuropharma, S.A. | N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors |
| PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
| JP5386350B2 (ja) * | 2006-05-31 | 2014-01-15 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼ活性剤としての、インダゾールおよびイソインドール誘導体 |
| ME00681B (me) | 2006-10-19 | 2011-12-20 | Takeda Pharmaceuticals Co | Jedinjenje indola |
| WO2008074694A1 (en) * | 2006-12-20 | 2008-06-26 | F. Hoffmann-La Roche Ag | Crystallization of glucokinase activators |
| JP5419706B2 (ja) | 2006-12-20 | 2014-02-19 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼアクチベーター |
| US8173645B2 (en) | 2007-03-21 | 2012-05-08 | Takeda San Diego, Inc. | Glucokinase activators |
| BRPI0812594A2 (pt) * | 2007-08-10 | 2015-06-23 | Lundbeck & Co As H | Composto ou sal ou hidrato do mesmo, composição farmacêutica, métodos para modulação da atividade de um receptor p2x7, para tratamento de uma condição responsiva á modulação do receptor p2x7 em um paciente, para inibição de morte de células gangliônicas retinais em um paciente, para determinação da presença ou ausência de receptor p2x7 em uma amostra, preparação farmacêutica acondicionada, e, uso de um composto ou sal ou hidrato do mesmo. |
| CA2724116A1 (en) * | 2008-05-16 | 2009-11-19 | Takeda San Diego, Inc. | Glucokinase activators |
| ES2528946T3 (es) | 2009-03-20 | 2015-02-13 | University Of Virginia Patent Foundation | Benzotiofeno-nitrotiazolida y otros antimicrobianos de amplio espectro |
| JP2011006366A (ja) | 2009-06-26 | 2011-01-13 | Sanwa Kagaku Kenkyusho Co Ltd | 新規チオフェンカルボキサミド誘導体及びその医薬用途 |
| US9333193B2 (en) | 2010-09-20 | 2016-05-10 | University Of Virginia Patent Foundation | Compositions and methods for treating tuberculosis |
| CN103044310B (zh) * | 2013-01-18 | 2015-02-04 | 贵阳医学院 | 二氢吲哚-3-乙酸衍生物、其制备方法以及在药物中的应用 |
| WO2023067628A1 (en) * | 2021-10-20 | 2023-04-27 | Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) | A method for the preparation of indole-3-carboxylic acid derivatives |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2740686B1 (fr) | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
| US6262096B1 (en) | 1997-11-12 | 2001-07-17 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| US6040321A (en) | 1997-11-12 | 2000-03-21 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| JP5278983B2 (ja) | 1999-11-17 | 2013-09-04 | 塩野義製薬株式会社 | アミド化合物の新規用途 |
| US6433188B1 (en) | 2000-12-06 | 2002-08-13 | Wendy Lea Corbett | Fused heteroaromatic glucokinase activators |
| KR100545431B1 (ko) | 2000-12-06 | 2006-01-24 | 에프. 호프만-라 로슈 아게 | 축합된 이종방향족 글루코키나제 활성화제 |
| US6482951B2 (en) | 2000-12-13 | 2002-11-19 | Hoffmann-La Roche Inc. | Isoindolin-1-one glucokinase activators |
| RU2290403C2 (ru) * | 2000-12-28 | 2006-12-27 | Дайити Фармасьютикал Ко., Лтд. | Ингибиторы vla-4 |
| UA77303C2 (en) * | 2002-06-14 | 2006-11-15 | Pfizer | Derivatives of thienopyridines substituted by benzocondensed heteroarylamide useful as therapeutic agents, pharmaceutical compositions and methods for their use |
-
2003
- 2003-09-26 AT AT03750648T patent/ATE374768T1/de not_active IP Right Cessation
- 2003-09-26 RU RU2005113719/04A patent/RU2309956C2/ru not_active IP Right Cessation
- 2003-09-26 CN CNB038236796A patent/CN100348596C/zh not_active Expired - Fee Related
- 2003-09-26 EP EP03750648A patent/EP1549638B1/en not_active Expired - Lifetime
- 2003-09-26 AU AU2003270285A patent/AU2003270285B2/en not_active Ceased
- 2003-09-26 NZ NZ538466A patent/NZ538466A/en unknown
- 2003-09-26 SI SI200331008T patent/SI1549638T1/sl unknown
- 2003-09-26 DK DK03750648T patent/DK1549638T3/da active
- 2003-09-26 DE DE60316709T patent/DE60316709T2/de not_active Expired - Lifetime
- 2003-09-26 ES ES03750648T patent/ES2293005T3/es not_active Expired - Lifetime
- 2003-09-26 PL PL03375149A patent/PL375149A1/xx not_active Application Discontinuation
- 2003-09-26 WO PCT/EP2003/010776 patent/WO2004031179A1/en active IP Right Grant
- 2003-09-26 CA CA002499329A patent/CA2499329C/en not_active Expired - Fee Related
- 2003-09-26 JP JP2004540731A patent/JP4390704B2/ja not_active Expired - Fee Related
- 2003-09-26 BR BR0315047-0A patent/BR0315047A/pt not_active IP Right Cessation
- 2003-09-26 MX MXPA05003391A patent/MXPA05003391A/es active IP Right Grant
- 2003-09-26 KR KR1020057005669A patent/KR100646486B1/ko not_active IP Right Cessation
- 2003-09-26 PT PT03750648T patent/PT1549638E/pt unknown
- 2003-09-30 TW TW092127030A patent/TW200413364A/zh unknown
- 2003-09-30 PA PA20038584001A patent/PA8584001A1/es unknown
- 2003-09-30 PE PE2003000988A patent/PE20050090A1/es not_active Application Discontinuation
- 2003-09-30 US US10/674,481 patent/US6881844B2/en not_active Expired - Fee Related
- 2003-10-01 UY UY28005A patent/UY28005A1/es not_active Application Discontinuation
- 2003-10-01 AR ARP030103589A patent/AR041467A1/es unknown
- 2003-10-01 MY MYPI20033742A patent/MY136764A/en unknown
-
2005
- 2005-03-01 NO NO20051103A patent/NO20051103L/no not_active Application Discontinuation
- 2005-03-24 HR HR20050287A patent/HRP20050287A2/xx not_active Application Discontinuation
-
2006
- 2006-01-19 ZA ZA200502619A patent/ZA200502619B/en unknown
- 2006-04-10 HK HK06104334A patent/HK1083098A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20050287A2 (en) | Indole-3-carboxamides as glucokinase (gk) activators | |
| MY135222A (en) | Substituted phenylacetamides and their use as glucokinase activators | |
| MA26973A1 (fr) | Activateurs glucokinase isoindolin-1-one | |
| MY136926A (en) | Glucokinase activators | |
| ATE381539T1 (de) | Dipeptidylpeptidase-hemmer zur behandlung von diabetes | |
| GB0209891D0 (en) | Novel compounds | |
| PT1311504E (pt) | Tetrazolil-fenil-acetamidas activadoras da glucoquinase | |
| MY145590A (en) | Phenylacetamides and their use as glucokinase modulators | |
| MX2007000505A (es) | Derivados de oxindol sustituidos y medicamentos que contienen los mismos. | |
| DK1864975T3 (da) | Nikotinamid-derivater anvendelige som P38-inhibitorer | |
| NO20076658L (no) | Heteroarylbenzamidderivater for anvendelse som GLK aktivatorer ved behandling av diabetes | |
| EA200600203A1 (ru) | Производные 2-(хиноксалин-5-илсульфониламино)бензамида в качестве модуляторов сск2 | |
| MX2008001778A (es) | Combinacion de un agente hipnotico y un compuesto de bis arilo y heteroarilo sustituido y aplicacion terapeutica de la misma. | |
| TW200407133A (en) | Novel PPARα and PPARγ agonists | |
| ATE449066T1 (de) | Biguanidderivate | |
| ATE458482T1 (de) | Verwendung von amino substituierten benzimidazolen | |
| MY140194A (en) | Novel fusidic acid derivatives | |
| TW200603800A (en) | 4-arylmorpholin-3-one derivatives, preparation thereof and therapeutic application thereof | |
| DE50304524D1 (de) | Arzneimittel enthaltend substituierte 2,5-diaminomethyl-1h-pyrrole | |
| TW200514780A (en) | Tri(cyclo)substituted amide glucokinase activator compounds | |
| SG145574A1 (en) | Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same | |
| TW200510447A (en) | Novel fusidic acid derivatives | |
| JO2238B1 (en) | Glycine stimulants iswindline 1- on |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20080822 Year of fee payment: 6 |
|
| OBST | Application withdrawn |